Le @CRPP12 et l'@AFH_Officiel organisent le 1er weekend d'éducation thérapeutique du patient 100% pathologies plaquettaires!
📍Strasbourg
📅19 et 20 novembre 2022.
Pour vous inscrire: https://t.co/QocCFVpPvl
Plus d'infos: https://t.co/unZ6blh05B et https://t.co/JyWB4oFRbC
Our group @aphm_actu and @univamu published a randomized trial of a physical activity program for children with cancer. Benefits : exercise capacity, self-esteem, quality of life.
🙏 share and help children and adolescents with cancer #keepmoving.
#Sport#ChildhoodCancer#QoL
@WorldSIOP@ecancer @univamu @aphm_actu @S_a_l_V @valletclothilde@SIOPEurope Thank you @WorldSIOP for sharing !
We're grateful to @S_a_l_V for providing the children with cancer treated at @aphm_actu such a great support, including a gym in the ward. Hopefully, access to adapted physical activity for children with cancer will keep growing worldwide.
Our study is finally published in @jclinicalinvest!
Anti-leukemic activity in the absence of severe toxicities with nonviral Sleeping Beauty–engineered CAR T cells. Thanks to all our great collaborators.
#Immunotherapy#tcells#GeneTherapy
https://t.co/TUttB9Q7sj
How #hemoglobin complex evolved from an ancestral monomer to a modern tetramer ?
Fascinating insights into the evolution of the protein complex mediating respiratory #oxygen transport.
https://t.co/mMxsKsGbnE
Higher than anticipated frequency of germline RUNX1 mutations among patients with RUNX1-mutated acute myeloid #leukemia. This study suggest specific pathophysiology.
#predisposition @BloodJournal